Two Sigma Investments’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,808
Closed -$40K 3540
2024
Q4
$40K Sell
13,808
-13,052
-49% -$38K ﹤0.01% 3063
2024
Q3
$93.2K Sell
26,860
-1,756
-6% -$6.36K ﹤0.01% 2908
2024
Q2
$111K Buy
28,616
+11,616
+68% +$111K ﹤0.01% 2812
2024
Q1
$242K Buy
+17,000
New +$242K ﹤0.01% 2641

Other funds holding BOLD

Two Sigma Investments's BOLD Position: Q1 2025 in Review

Two Sigma Investments sold out of Boundless Bio (BOLD) in Q1 2025, closing a stake of 13,808 shares — an estimated $40K sold.

Two Sigma Investments first reported a position in BOLD in Q1 2024 and held it in 4 quarters. The position peaked at $242K in Q1 2024. 54 funds tracked by Wall St. Rank hold BOLD as of Q1 2025.

  • Two Sigma Investments reported no remaining Boundless Bio position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 13,808 Boundless Bio shares in Q1 2025, an estimated $40K.
  • Two Sigma Investments first reported a position in Boundless Bio in Q1 2024 and held it in 4 quarters.
  • Two Sigma Investments's Boundless Bio position peaked at $242K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.